Study Summary
This trial is testing if a new way of treating prostate cancer, ultra-hypofractionation, is effective and has less urinary side effects.
- Prostate Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: up to 5 year post radiation
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Hypofrac Radiation Therapy
1 of 1
Experimental Treatment
30 Total Participants · 1 Treatment Group
Primary Treatment: Hypofractionated Radiation · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 11 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is recruitment still underway for this experiment?
"Precisely. Clinicaltrials.gov documents that, as of September 1st 2020, this investigation is actively seeking enrolment from 30 participants at one medical centre - the study was originally published on March 22nd 2018." - Anonymous Online Contributor
How many participants are being enrolled in this research endeavor?
"Indeed, based on the information provided online by clinicaltrials.gov, this study is currently seeking participants. It was posted on March 22nd 2018 and last edited September 1st 2020; with 30 volunteers being sought from a single location." - Anonymous Online Contributor